Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effects of interleukin-21 in the biology of transplant rejection. | Front Immunol | 2025 | 40376002 | PubTator, text mining | PubMed |
| The NF-κB signaling network in the life of T cells. | Front Immunol | 2025 | 40370445 | PubTator, text mining | PubMed |
| Computational Design of a Bicyclic Peptide Inhibitor Targeting the ICOS/ICOS-L Protein-Protein Interaction. | Chem Biol Drug Des | 2025 | 40317592 | PubTator, text mining | PubMed |
| Multiplex immunophenotyping of human acute myeloid leukemia patients revealed single -cell heterogeneity with special attention on therapy sensitive and therapy resistant subpopulations. | Front Immunol | 2025 | 40313947 | PubTator, text mining | PubMed |
| Conjunctival MicroRNA Expression Signature in Primary Sjögren's Syndrome Dry Eye: A NanoString-Based Bioinformatic Analysis. | Invest Ophthalmol Vis Sci | 2025 | 40298889 | PubTator, text mining | PubMed |
| ICOS and ICOS ligand: expression patterns and outcomes in oncology patients. | Ther Adv Med Oncol | 2025 | 40297627 | PubTator, text mining | PubMed |
| miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas. | Proc Natl Acad Sci U S A | 2025 | 40249785 | PubTator, text mining | PubMed |
| Identification of Recurrence-associated Gene Signatures and Machine Learning-based Prediction in IDH-Wildtype Histological Glioblastoma. | J Mol Neurosci | 2025 | 40227386 | PubTator, text mining | PubMed |
| The Immune Environment in Colorectal Adenoma: A Systematic Review. | Biomedicines | 2025 | 40149674 | PubTator, text mining | PubMed |
| In situ tumor cell engineering reverses immune escape to enhance immunotherapy effect. | Acta Pharm Sin B | 2025 | 40041911 | PubTator, text mining | PubMed |
| Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer. | J Immunother Cancer | 2025 | 40010771 | PubTator, text mining | PubMed |
| Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells. | Int J Mol Sci | 2025 | 40004038 | PubTator, text mining | PubMed |
| ICOSL, OX40L, and CD30L control persistence of asthmatic CD4 tissue-resident memory CD4 T cells. | J Allergy Clin Immunol | 2025 | 39921040 | PubTator, text mining | PubMed |
| Microwave Ablation Combined with Flt3L Provokes Tumor-Specific Memory CD8+ T Cells-Mediated Antitumor Immunity in Response to PD-1 Blockade. | Adv Sci (Weinh) | 2025 | 39629989 | PubTator, text mining | PubMed |
| Aire attenuate collagen-induced arthritis by suppressing T follicular helper cells through ICOSL. | Int Immunopharmacol | 2025 | 39626537 | PubTator, text mining | PubMed |
| ICOSL deficiency promotes M1 polarization to alleviate liver fibrosis in schistosomiasis mice. | Acta Trop | 2025 | 39581561 | PubTator, text mining | PubMed |
| CD34+ and CD34- MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells. | Int J Hematol | 2025 | 39531203 | PubTator, text mining | PubMed |
| Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis. | Hepatology | 2025 | 39058584 | PubTator, text mining | PubMed |
| Characterization of Dendritic Cells and Myeloid-Derived Suppressor Cells Expressing Major Histocompatibility Complex Class II in Secondary Lymphoid Organs in Systemic Lupus Erythematosus-Prone Mice. | Int J Mol Sci | 2024 | 39769367 | PubTator, text mining | PubMed |
| ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma. | Int J Mol Sci | 2024 | 39596506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=5